Botox 200unit Inj, 1 Vial

OnabotulinumtoxinA acts by blocking cholinergic nerve terminals, inhibiting the release of acetylcholine at the neuromuscular junction. This inhibition occurs through the cleavage of SNAP-25, a protein essential for the successful docking and fusion of acetylcholine vesicles with the presynaptic membrane, leading to muscle paralysis or reduction in glandular secretion.

Urgent Side Effects: Seek Medical Help Right Away

Although rare, this medication can cause severe and potentially life-threatening side effects. If you experience any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of infection, including:
+ Fever
+ Chills
+ Severe sore throat
+ Ear or sinus pain
+ Cough
+ Increased or discolored sputum
+ Painful urination
+ Mouth sores
+ Wounds that won't heal
Changes in vision, eye pain, or severe eye irritation
Sensitivity to bright lights
Drooping eyebrows
Dizziness or fainting
Seizures
Heart problems, such as:
+ Chest pain or pressure
+ Abnormal heartbeat (arrhythmia)
If you're taking this medication for loss of bladder control, watch for signs of a urinary tract infection (UTI), including:
+ Blood in the urine
+ Burning or pain while urinating
+ Frequent or urgent need to urinate
+ Fever
+ Lower abdominal pain
+ Pelvic pain
Trouble urinating

Other Possible Side Effects

Like all medications, this drug can cause side effects. While many people may not experience any side effects or only mild ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects, contact your doctor if they bother you or don't go away:

Irritation at the injection site
Neck pain
Arm or leg pain
Headache
Decreased blinking
Dry eyes
Dry mouth
Cough
Flu-like symptoms
Back pain
Runny nose
Fatigue or weakness
Mild fever
Upset stomach
Drowsiness
Common cold symptoms

Reporting Side Effects

This list is not exhaustive, and you may experience other side effects. If you have questions or concerns, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.

Before Taking This Medication: Important Information to Share with Your Doctor

To ensure safe and effective treatment, it is crucial to inform your doctor about the following:

Any allergies you have to this medication, its components, or other substances, including foods and drugs. Describe the allergic reaction you experienced, such as symptoms and signs.
The presence of an infection at the intended injection site.
If you have been diagnosed with a condition that affects your muscles and nerves, such as myasthenia gravis, Lambert-Eaton syndrome, or amyotrophic lateral sclerosis (ALS).

Additional Considerations for Loss of Bladder Control:

If you currently have a urinary tract infection.
If you experience difficulty passing urine.
If you are unable to empty your bladder on your own.

This list is not exhaustive, and it is essential to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health issues with your doctor and pharmacist. They will help determine if it is safe to take this medication with your existing treatments and health conditions. Never start, stop, or adjust the dosage of any medication without consulting your doctor first.

Important Warnings and Cautions

General Precautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. If you have received a botulinum toxin product within the last 3 or 4 months, discuss this with your doctor. Additionally, avoid driving and performing tasks that require alertness or clear vision until you understand how this medication affects you.

Off-Label Use and Severe Side Effects

In cases where this medication has been used for unapproved purposes, severe side effects such as extreme weakness and swallowing difficulties have occurred. These side effects can be life-threatening, especially in individuals with pre-existing swallowing problems or other health issues. It is crucial to discuss these risks with your doctor.

Infection Risk

As this medication is derived from human plasma, there is a risk of transmitting viruses that can cause disease. Although the medication is thoroughly screened, tested, and treated to minimize this risk, it is essential to discuss this with your doctor.

Pregnancy and Breastfeeding

If you are pregnant, plan to become pregnant, or are breastfeeding, inform your doctor. You and your doctor will need to weigh the benefits and risks of using this medication to ensure the best possible outcome for you and your baby.

Special Considerations for Loss of Bladder Control

If you are 65 years or older and using this medication for loss of bladder control, exercise caution. You may be more susceptible to side effects, and your doctor will need to closely monitor your condition.

• Aminoglycoside antibiotics (e.g., gentamicin, tobramycin)
• Other agents interfering with neuromuscular transmission (e.g., curare-like non-depolarizing blockers, succinylcholine, spectinomycin, polymyxins, tetracyclines, lincomycin)

• Anticholinergic agents (may potentiate systemic anticholinergic effects)
• Muscle relaxants (may potentiate muscle weakness)

• Generalized muscle weakness
• Vision changes (e.g., blurred vision, double vision, drooping eyelids)
• Difficulty swallowing (dysphagia)
• Difficulty speaking (dysphonia)
• Loss of voice (aphonia)
• Breathing difficulties (dyspnea)
• Loss of bladder control
• Severe allergic reactions (e.g., rash, itching, hives, swelling of the face/lips/tongue/throat, wheezing, dizziness, fainting)

OnabotulinumtoxinA is Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus.

It is not known whether OnabotulinumtoxinA is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother. Lactation risk is L3 (moderately safe).

Approved for specific indications in pediatric patients 2 years of age and older (e.g., upper and lower limb spasticity). The risk of distant toxin spread may be greater in children treated for spasticity. Dosing is weight-based and indication-specific. Not approved for cosmetic use in pediatric patients.

Clinical studies did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy. Elderly patients may be at increased risk for adverse events, particularly generalized weakness or dysphagia.

• Botox unit potency is specific to the product and not interchangeable with other botulinum toxin products (e.g., Dysport, Xeomin, Jeuveau, Daxxify).
• Reconstitution: Botox 200 units should be reconstituted with sterile, preservative-free 0.9% Sodium Chloride Injection. The amount of diluent varies by indication and desired concentration.
• Injection technique is crucial to minimize adverse effects and maximize efficacy. Injections should be precise and into the target muscle(s).
• Patients should be advised about the potential for distant spread of toxin effect, especially if they have pre-existing conditions that might predispose them to such effects.
• Anticoagulant use: Caution is advised when administering Botox to patients on anticoagulant therapy or with bleeding disorders, as bruising or bleeding may occur at the injection site.
• Immunogenicity: The formation of neutralizing antibodies to botulinum toxin type A may reduce the effectiveness of subsequent Botox treatments. This risk increases with higher cumulative doses and more frequent injections.

• AbobotulinumtoxinA (Dysport)
• IncobotulinumtoxinA (Xeomin)
• PrabotulinumtoxinA (Jeuveau)
• DaxibotulinumtoxinA (Daxxify)
• For spasticity: Physical therapy, occupational therapy, oral muscle relaxants (e.g., baclofen, tizanidine), intrathecal baclofen pump, surgery.
• For chronic migraine: Oral prophylactic medications (e.g., topiramate, beta-blockers), CGRP inhibitors, nerve blocks.
• For hyperhidrosis: Topical antiperspirants, iontophoresis, oral anticholinergics, surgery.
• For cosmetic indications: Dermal fillers, laser therapy, chemical peels, surgical procedures.

If your symptoms or health issues persist or worsen, it is essential to contact your doctor promptly. To ensure safe use, never share your medication with others or take someone else's medication. Store all medications in a secure location, out of reach of children and pets, to prevent accidental ingestion. Dispose of unused or expired medications properly. Unless instructed to do so by a healthcare professional, do not flush medications down the toilet or drain. If you are unsure about the correct disposal method, consult your pharmacist, who can also inform you about potential drug take-back programs in your area.

This medication is accompanied by a Medication Guide, a patient fact sheet that provides crucial information. It is essential to read this guide carefully and review it again each time your prescription is refilled. If you have any questions or concerns about this medication, discuss them with your doctor, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately contact your local poison control center or seek medical attention. Be prepared to provide information about the medication taken, the quantity, and the time of ingestion.